ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,086.37
0.61%
US Tech 100
21,213.60
1.06%
다우존스 지수
44,156.73
0.30%
Bitcoin
102,344.85
-1.24%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 영국
  5. LSE

  6. Uniphar Plc (UPR) 시세

Uniphar Plc

Uniphar Plc (UPR)

LSE
173.00
0.00
(0.00%)
마감 23 1월 1:30AM
15분 지연

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

프리미엄

주요 통계 및 세부정보

가격
173.00
매수가
170.00
매도가
176.00
거래량
150,050
173.00 일간 변동폭 173.00
165.00 52주 범위 252.00
market_cap
472.316M
전일 종가
173.00
개장가
173.00
최근 거래 시간
86000
@
175
(O)
마지막 거래 시간
재정 규모
-
VWAP
-
평균 볼륨(3m)
10,959
발행 주식
273,015,254
배당수익률
1.27%
주가수익률
10.54
주당순이익(EPS)
0.16
매출
2.55B
순이익
44.82M

Uniphar Plc 정보

섹터
Drug & Proprietary Stores
산업
Drug & Proprietary Stores
웹사이트
www.uniphar.ie
본부
Dublin, Irl
설립됨
-
Uniphar Plc is listed in the Drug & Proprietary Stores sector of the 런던증권거래소 with ticker UPR. The last closing price for Uniphar was 173p. Over the last year, Uniphar shares have traded in a share price range of 165.00p to 252.00p.

Uniphar currently has 273,015,254 shares in issue. The market capitalisation of Uniphar is £472.32 million. Uniphar has a price to earnings ratio (PE ratio) of 10.54.

UPR 최신 뉴스

추가 뉴스

Uniphar PLC Holding(s) in Company

Uniphar PLC 16 December 2024   Uniphar plc   Holding(s) in Company   Dublin | 16 December 2024: Uniphar plc (the "Company"), was notified by Allianz Global Investors GmbH on 13 December 2024...

16 12월 2024
RNS Regulatory News

Uniphar PLC Director/PDMR Shareholding

Uniphar PLC 02 December 2024   Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them  [This form is required for disclosure...

02 12월 2024
RNS Regulatory News

Uniphar PLC Holding(s) in Company

Uniphar PLC 29 November 2024   Uniphar plc   Holding(s) in Company   Dublin | 29 November 2024: Uniphar plc (the "Company"), was notified by Allianz Global Investors GmbH on 29 November 2024...

30 11월 2024
RNS Regulatory News

Uniphar "well-positioned" to achieve targets after profit growth

Uniphar PLC said on Tuesday that it remained "well-positioned" to deliver current market expectations, with profit gr ...

03 9월 2024
Alliance News

Uniphar PLC 2024 Interim Results

Uniphar PLC 03 September 2024   Uniphar plc 2024 Interim Results   Uniphar plc, an international diversified healthcare services business, announces its half year results for the six months...

03 9월 2024
RNS Regulatory News

Uniphar says on track to meet expectations for gross profit for 2024

Uniphar PLC on Tuesday announced it expects to meet own expectations for gross profit and earnings before interest, t ...

30 7월 2024
Alliance News

Uniphar PLC Half Year Trading Update and Notice of Results

Uniphar PLC 30 July 2024     Uniphar plc   Half-Year Trading Update and Notice of Results   Dublin, London | 30 July 2024: Uniphar plc (the "Group" or "Uniphar"), an international diversified...

30 7월 2024
RNS Regulatory News

Uniphar PLC Holding(s) in Company

Uniphar PLC 24 June 2024   Standard Form TR-1 Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the Central Bank of...

24 6월 2024
RNS Regulatory News

Uniphar PLC Director/PDMR Shareholding

Uniphar PLC 21 May 2024   Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them    [This form is required for disclosure of...

21 5월 2024
RNS Regulatory News

Uniphar PLC Holding(s) in Company

Uniphar PLC 17 May 2024   TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if...

17 5월 2024
RNS Regulatory News
기간변동변동 %시가고가저가평균 일일 거래량VWAP
16.53.9039039039166.5174166.524541173.11908041DE
442.36686390533169177.516512909172.37650487DE
12-21-10.82474226819419416510959178.30524236DE
26-27-13.520023216513615202.01538566DE
52-46-21.0045662121925216528424218.1342266DE
156-165-48.816568047333834516529636241.92827313DE
260171.71513363.03501951.2854101.03531673210.19995062DE

UPR - Frequently Asked Questions (FAQ)

What is the current Uniphar share price?
The current share price of Uniphar is 173.00p
How many Uniphar shares are in issue?
Uniphar has 273,015,254 shares in issue
What is the market cap of Uniphar?
The market capitalisation of Uniphar is GBP 472.32M
What is the 1 year trading range for Uniphar share price?
Uniphar has traded in the range of 165.00p to 252.00p during the past year
What is the PE ratio of Uniphar?
The price to earnings ratio of Uniphar is 10.54
What is the cash to sales ratio of Uniphar?
The cash to sales ratio of Uniphar is 0.18
What is the reporting currency for Uniphar?
Uniphar reports financial results in EUR
What is the latest annual turnover for Uniphar?
The latest annual turnover of Uniphar is EUR 2.55B
What is the latest annual profit for Uniphar?
The latest annual profit of Uniphar is EUR 44.82M
What is the registered address of Uniphar?
The registered address for Uniphar is 4045 KINGSWOOD ROAD, CITYWEST BUSINESS PARK, DUBLIN, D24 VO6K
What is the Uniphar website address?
The website address for Uniphar is www.uniphar.ie
Which industry sector does Uniphar operate in?
Uniphar operates in the DRUG & PROPRIETARY STORES sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
EXREngage Xr Holdings Plc
2.00p
(190.91%)
94M
LLAILunglife Ai Inc
11.75p
(30.56%)
1.16M
TM1Technology Minerals Plc
0.14p
(27.27%)
78.39M
PYCPhysiomics Plc
1.05p
(27.27%)
41.18M
VASTVast Resources Plc
0.1325p
(26.19%)
245.04M
TRCThe Revel Collective Plc
0.275p
(-31.25%)
7.26M
MILAMila Resources Plc
0.225p
(-30.77%)
41.77M
MODER8 Capital Investments Plc
1.65p
(-26.67%)
5.59M
HOCHochschild Mining Plc
190.80p
(-16.68%)
9.86M
STKStreaksai Plc
1.05p
(-16.00%)
1.06M
NTVONativo Resources Plc
0.0021p
(5.00%)
1.33B
TRPTower Resources Plc
0.0295p
(-3.28%)
443.63M
PREMPremier African Minerals Limited
0.0255p
(-4.14%)
435.82M
SYMESupply@me Capital Plc
0.0031p
(-7.46%)
392.02M
RRRRed Rock Resources Plc
0.06p
(20.00%)
312.39M

토론

전체 피드 보기
jour_trader jour_trader 3 분 전
Minutes posted from call, but behind a paywall. 

https://www.pacermonitor.com/public/case/51356241/PURDUE_PHARMA_LP_et_al_v_ELITE_LABORATORIES_INC,_et_al
ELTP
ace65 ace65 8 분 전
When the pigs at the trough get their fill we will have a
HMBL type run.
And the pause of ongoing dilution of course.
HMBL
Dumb&dumber4long Dumb&dumber4long 8 분 전
Let’s focus on TNXP, stick politics somewhere else & other subjects too.
TNXP
22rover 22rover 9 분 전
It's important to remember that legacy holders have invested at or above 0.18 cents. If they are not following sidechannel’s progress, the reality they see is a thinly traded penny stock lingering near its all-time lows.

They phone their broker to sell the stock. Broker says, yeah, i
SDCH
pegs1 pegs1 9 분 전
I think it’s very unprofessional for management to not inform investors of the closing of the lab including departure of scientists! This just continues to be full of surprises ……
CRTG
gp22 gp22 12 분 전
ASNS: AI infrastructure stocks are getting hot coming off the massive $ORCL AI Infrastucture deal just announced.
$ASNS the cheapest microfloat AI Infrastructure stock. Top management. Starting to rip. Has recent upgrade from highly regarded Litchfield. Do not miss $ASNS.
$ASNS has 6K
ASNS BFAI ORCL
gp22 gp22 12 분 전
ASNS: AI infrastructure stocks are getting hot coming off the massive $ORCL AI Infrastucture deal just announced.
$ASNS the cheapest microfloat AI Infrastructure stock. Top management. Starting to rip. Has recent upgrade from highly regarded Litchfield. Do not miss $ASNS.
$ASNS has 6K
ASNS BFAI ORCL
gp22 gp22 12 분 전
ASNS: AI infrastructure stocks are getting hot coming off the massive $ORCL AI Infrastucture deal just announced.
$ASNS the cheapest microfloat AI Infrastructure stock. Top management. Starting to rip. Has recent upgrade from highly regarded Litchfield. Do not miss $ASNS.
$ASNS has 6K
ASNS BFAI ORCL
SkyLimit2022 SkyLimit2022 15 분 전
suit,

Thanks for posting the MHRA link!
https://investorshub.advfn.com/uimage/uploads/2024/10/21/zqal[200.gif
https://investorshub.advfn.com/uimage/uploads/2024/10/24/nqdtigiphy.gif

That’s exactly the kind of regulatory support that Advent has provided wh
NWBO
noradio noradio 16 분 전
Pm'd
DBMM
AlwaysOptimistic AlwaysOptimistic 16 분 전
I agree with you NorCal. Either the current mgt delivers financing this year or just sell the mine as you suggested to a large mining co that can deliver results. Many of us are stuck with shares that have fallen to lows that are not even worth selling. Would like to see a rebound and recoup our or
NB
The GidDy uP Kid The GidDy uP Kid 20 분 전
CNSP, readying for a Bullish Hammer tomorrow… 
https://schrts.co/cBIMqiew
CNSP
The GidDy uP Kid The GidDy uP Kid 20 분 전
CNSP, readying for a Bullish Hammer tomorrow… 
https://schrts.co/cBIMqiew
CNSP
The GidDy uP Kid The GidDy uP Kid 20 분 전
CNSP, readying for a Bullish Hammer tomorrow… 
https://schrts.co/cBIMqiew
CNSP
harry crumb harry crumb 22 분 전
Lets see 1.50 tomorrow or lower boys! Jam it at open! Lets roll $$$$$$
ILLR
XMaster2023 XMaster2023 22 분 전
Theory, Approval of DCVax is near!
NWBO
Plato_ Plato_ 23 분 전
Yup, that's the way I understand it. Whether the contract is paid up front or on performance, the revenue is recognized when earned and deferred revenue is reduced to match. Good example with the labor-based contract. Same principle. You make a good point about the intellectual property. If this is
GDVM
boi568 boi568 24 분 전
Statutes and regulations will always trump guidances, assuming the statutes or regulations address the issue the guidance is addressing. The reason agencies issue guidance is because the statutes and regulations haven't addressed the issue.

So, if you can find an FDA statute or regula
AVXL
boi568 boi568 24 분 전
Statutes and regulations will always trump guidances, assuming the statutes or regulations address the issue the guidance is addressing. The reason agencies issue guidance is because the statutes and regulations haven't addressed the issue.

So, if you can find an FDA statute or regula
AVXL
3331 3331 25 분 전
3331 has been restricted to one post per day:

BIEL HITS COPPER "IN THE BLINK OF AN EYE" WHEN THE FOLLOWING OCCURS!

pps > .001 after management drops some positive hints. The Golden Cross (already achieved) and Blue Sky Breakout will get the technicians/chartists attenti
QUBT SERV
theorysuit theorysuit 26 분 전
https://cms.mhra.gov.uk/mhra/mia/uk-miaimp-54923

Oh you are talking about this MIA. Unfortunately, i only see ADVENT on this MIA. No sight of NWBO at all. Like i said congrats to LP not NWBO.


https://find-and-update.company-information.service.gov.uk/company
NWBO
HomerRomer HomerRomer 27 분 전
This is a response to Missling’s LinkedIn post by a VERY educated and qualified senior vice president of Red Nucleus who manages and provides strategic oversight and tactical back up for clinical teams.  He seems to think Blarcamesine  could likely work better than the study results show. 
AVXL

최근 히스토리

LSE
UPR
Uniphar
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유